Context Therapeutics Inc banner

Context Therapeutics Inc
F:6K9

Watchlist Manager
Context Therapeutics Inc Logo
Context Therapeutics Inc
F:6K9
Watchlist
Price: 2 EUR 1.52% Market Closed
Market Cap: €150m

Dividends

Context Therapeutics Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for 6K9 is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

6K9 Price
Context Therapeutics Inc

Annual Price Range
2
52w Low
0.444
52w High
3.12
Price Metrics
Average Annual Return -17.21%
Standard Deviation of Annual Returns 62.94%
Max Drawdown -94%
Shares Statistics
Market Capitalization 218.7m EUR
Shares Outstanding 75 000 000
Percentage of Shares Shorted
N/A

6K9 Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about 6K9's stock splits.

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett